- Report
- August 2022
United States
From €1766EUR$1,940USD£1,514GBP
- Report
- August 2022
Global
From €992EUR$1,090USD£850GBP
- Report
- August 2022
Global
From €901EUR$990USD£772GBP
- Report
- August 2022
Global
From €901EUR$990USD£772GBP
- Report
- August 2022
Global
From €901EUR$990USD£772GBP
- Report
- August 2022
Global
From €901EUR$990USD£772GBP
- Report
- August 2022
Global
From €992EUR$1,090USD£850GBP
- Report
- August 2022
Global
From €719EUR$790USD£616GBP
- Report
- August 2021
Global
From €3631EUR$3,990USD£3,113GBP
- Report
- February 2021
Global
From €2694EUR$2,960USD£2,309GBP
- Report
- November 2019
- 50 Pages
Global
From €1050EUR$1,236USD£932GBP
- Report
- November 2021
- 213 Pages
Global
From €3640EUR$4,000USD£3,121GBP
- Report
- April 2024
- 80 Pages
Argentina
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Brazil
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
China
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
France
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Germany
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
India
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Ireland
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Japan
From €1365EUR$1,500USD£1,170GBP

The Analgesics market is a sector of the pharmaceutical industry that focuses on the production and sale of drugs used to relieve pain. Analgesics are used to treat a variety of conditions, including headaches, muscle pain, arthritis, and post-operative pain. Common analgesics include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and acetaminophen.
Analgesics are available in a variety of forms, including tablets, capsules, liquids, and topical creams. Many analgesics are available over-the-counter, while others require a prescription.
The analgesics market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the analgesics market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Merck. Show Less Read more